Purchase Order HHSN272201700922P
- Not listed
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Lakepharma, Inc., a minority-owned, for-profit biopharmaceutical contract development and manufacturing organization (CDMO). The $20,000 contract is for the "heavy and light humanization of 1B3 MAB", which involves antibody humanization services to support NIAID's medical research and healthcare mission. The...
- This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Lakepharma, Inc. for $21,769.00 in testing services. The contract has no set-aside designation and was completed on July 3, 2015. Lakepharma, Inc. is a Contract Development and Manufacturing Organization (CDMO) that provides pharmaceutical and biotech services, including affinity maturation, production of...
- This is a $5,545.00 firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Lakepharma, Inc., a minority-owned and Asian-Pacific American-owned for-profit organization. The contract is for custom antibody and protein purification services to be performed in Belmont, CA. Lakepharma, Inc. is a contract development and manufacturing organization (CDMO) that has previously...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $5,499 firm fixed price purchase order to Lakepharma, Inc., a minority-owned, for-profit Contract Development and Manufacturing Organization (CDMO). The award is for monoclonal antibody production and Zika research services. Lakepharma has previously provided similar services to other federal agencies such as the Department of Veterans Affairs and the National Institutes of Health. This award does not have a set-aside...
- This is a $6,891.78 firm fixed-price purchase order awarded by the National Institute of Mental Health (NIMH) to Lakepharma, Inc., a minority-owned, for-profit contract development and manufacturing organization (CDMO). The contract is for expression optimization and immunoaffinity capture (IMAC) pulldown services to support NIMH's internal research. The contract has a period of performance through September 9, 2025. There was no set-aside used for this award. Lakepharma has previously...
- The Department of Veterans Affairs Veterans Health Administration awarded a $130,145 firm-fixed-price purchase order to Lakepharma, Inc., a minority-owned, Asian-Pacific American-owned for-profit organization, to provide antibody humanization services. Lakepharma is a Contract Development and Manufacturing Organization (CDMO) that has previously supported federal agencies' medical research and healthcare missions through past contract awards for services such as affinity maturation, reagent...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $24,920.00 firm fixed-price purchase order contract to ABI Scientific Inc., a minority-owned and Asian-Pacific American-owned for-profit organization. The contract was awarded on September 24, 2018, with a completion date of October 24, 2018, and the place of performance is Bethesda, Maryland. This contract does not have a set-aside designation.
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to ABI Scientific Inc., a minority-owned and Asian-Pacific American-owned for-profit organization. The contract is for the delivery of 100 units of Adherent Cell Expression Media 250 ML at a total potential value of $12,340.00. The contract was awarded on January 30, 2018, with a completion date of January 30, 2019....
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a small, Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,958.95, is for the provision of various research and development services related to genetics, immunology, virology, and infectious diseases, including...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,272,675.00 firm fixed price delivery order to Pharmacology Discovery Services Taiwan, LTD., a Taiwanese for-profit organization. This delivery order was issued under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity contract vehicle. The work focuses on providing NIAID with therapeutic testing...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $3,799.00 firm-fixed-price purchase order contract to Lakepharma, Inc., a minority-owned, for-profit, Asian-Pacific American-owned business, for the cloning and sequencing of mouse hybridoma. The contract has a completion date of September 29, 2017 and was awarded on August 2, 2017. Lakepharma, Inc. is a Contract Development and Manufacturing Organization (CDMO) that provides pharmaceutical and biotech services to federal agencies, including the Department of Veterans Affairs, the National Institutes of Health, and the National Institute of Mental Health. This contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 8/2/17 |